Guiyang Xintian Pharmaceutical Co Ltd (002873) — Strategic Asset Allocation Index
Guiyang Xintian Pharmaceutical Co Ltd (002873) has a Strategic Asset Allocation Index of 54.5% as of September 2023. Strategic assets (PP&E of CN¥651.18 Million plus long-term investments of CN¥-) total CN¥651.18 Million, measured against net assets of CN¥1.20 Billion. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base.
SAAI
Strategic Assets
PP&E
Net Assets
Guiyang Xintian Pharmaceutical Co Ltd Strategic Asset Allocation Index (2015–2021)
This chart shows how Guiyang Xintian Pharmaceutical Co Ltd's Strategic Asset Allocation Index has evolved across 7 annual periods from 2015 to 2021. As of September 2023, the index stands at 54.5%, representing strategic assets of CN¥651.18 Million against net assets of CN¥1.20 Billion CNY. Explore Guiyang Xintian Pharmaceutical Co Ltd operating cash flow efficiency to assess how effectively this company generates cash.
Annual Strategic Asset Allocation Index for Guiyang Xintian Pharmaceutical Co Ltd (2015–2021)
The table below presents the year-by-year Strategic Asset Allocation Index for Guiyang Xintian Pharmaceutical Co Ltd from 2015 to 2021, covering 7 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For the full company profile including market capitalisation, see 002873 company net worth.
| Year | SAAI | Strategic Assets (CNY) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2021 | 52.1% | CN¥463.94 Million | CN¥463.94 Million | CN¥- | CN¥890.44 Million | ▲ +6.1 pp |
| 2020 | 46.0% | CN¥381.09 Million | CN¥381.09 Million | CN¥- | CN¥828.30 Million | ▼ -4.3 pp |
| 2019 | 50.3% | CN¥356.57 Million | CN¥356.57 Million | CN¥- | CN¥708.76 Million | ▲ +12.4 pp |
| 2018 | 37.9% | CN¥250.56 Million | CN¥250.56 Million | CN¥- | CN¥660.59 Million | ▼ -2.0 pp |
| 2017 | 39.9% | CN¥248.19 Million | CN¥248.19 Million | CN¥- | CN¥622.11 Million | ▼ -17.3 pp |
| 2016 | 57.2% | CN¥159.83 Million | CN¥159.83 Million | CN¥- | CN¥279.21 Million | ▼ -16.2 pp |
| 2015 | 73.4% | CN¥166.17 Million | CN¥166.17 Million | CN¥- | CN¥226.31 Million | — |